Vi Releases 2025 State of AI Reports: Transforming BioPharma, Healthcare, and Wellness with AI Disruption
Vi, the Enterprise-AI platform for health enterprises, today unveiled its 2025 State of AI Reports, providing an in-depth analysis of how artificial intelligence is shaping Healthcare, BioPharma, and Wellness. These reports highlight AI’s growing impact across industries, offering a data-driven roadmap for organizations to enhance efficiency, improve patient and member outcomes, and drive financial ROI.
With AI adoption accelerating across the health sector, these reports serve as a critical guide for enterprises navigating the complexities of AI implementation. The findings highlight AI’s role in transforming patient ROI, Member ROI, and Operational ROI—all while reducing costs and improving health outcomes.
Key Insights from the 2025 Reports:
Healthcare: Cutting Costs and Enhancing Care
With rising costs and operational inefficiencies, AI is becoming a critical tool for healthcare organizations:
- Automating administrative workflows reduces costs by 25-30%, freeing up resources for patient care.
- Predictive AI models improve patient activation, cutting costs by 30% while increasing health plan revenues by 7%.
- Personalized digital interventions lower hospital stays by 25% and reduce nursing facility discharges by 91%.
BioPharma: Accelerating Drug Development and Adherence
AI is transforming R&D and commercial operations, driving efficiency and reducing time to market:
- Precise and predictive patient recruitment improves trial enrollment by 80%, reducing approval timelines by up to two years.
- Precise and predictive adherence solutions improve medication compliance by 67%, addressing $290 billion in annual losses.
- Operational automation in R&D and commercial processes is projected to unlock $254 billion in additional value by 2030.
Wellness: Driving Personalization and Engagement
The wellness industry is leveraging AI to improve retention, engagement, and profitability:
- Personalized member experiences boost engagement by 20% and reduce churn by 35%.
- Precision-targeted marketing improves member acquisition, reducing cost-per-lead by up to 60%.
- Utilizing AI for hyper-personalization delivers 8x ROI in marketing, lifting sales by 10%.
“The 2025 State of AI Reports reveal how AI is reshaping healthcare, pharma, and wellness, providing a data-driven roadmap and best practices for organizations to navigate this historical transformation,” said Omri Yoffe, CEO of Vi. “With AI driving unprecedented advancements in patient care, clinical efficiency, and operational automation, these reports serve as a strategic guide for enterprises looking to harness AI’s full potential while addressing its adoption challenges.”
Vi Enterprise AI helps the world’s largest health organizations maximize business performance and health outcomes. Vi’s configurable platform, combined with licensed consumer behavioral data (SDOH, Mobility, Search, Purchases, Media, and more) on 96% of the US population and over 180 million lives on the platform, enables precise, predictive, and personalized enrollment, engagement and retention throughout the member lifecycle via optimized communications and operational automation.
Vi serves industry leaders such as top Biotech and Pharma brands, National Health Plans and Providers, and Wellness Operators, driving an average of 4.2X ROI on every dollar spent.
Headquartered in New York City and with teams in Tel Aviv, Boston, Austin, and Nashville, Vi remains committed to leveraging technology and data science to help people live better, healthier lives.
For Additional Information:
For further insights and to access ‘The State of AI in BioPharma Report’, ‘The State of AI in Healthcare Report’, and ‘The State of AI in Wellness Report 2025’, visit Vi.
media@vi.co
Vi Labs